| Name | Title | Contact Details |
|---|
NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics` extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation.
Tristan Associates c/o Breast Center is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
American Reliability Labs Inc is a Malden, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
cell signaling technology inc is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. We are headquartered in Cambridge UK. Our eight additional sales, production, and distribution offices are located in Asia, UK, and the USA. Our mission is to help scientists to discover more. Our vision is to be the brand most recommended by life science researchers. We recognise the importance of providing clear and timely information to our existing and potential shareholders and hope that you will find this website helpful on informing your investment decisions.